» Articles » PMID: 27842212

Urinary Tract Infection Caused by Community-acquired Extended-spectrum β-lactamase-producing Bacteria in Infants

Overview
Specialty Pediatrics
Date 2016 Nov 15
PMID 27842212
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Urinary tract infection (UTI) caused by resistant strains of bacteria is increasingly prevalent in children. The aim of this study was to investigate the clinical characteristics and risk factors for UTI caused by community-acquired extended-spectrum β-lactamase (CA-ESBL)-producing bacteria in infants.

Methods: This was a retrospective study performed over 5 years in a single Korean center. Hospitalized infants with febrile UTI were enrolled and divided into two groups (CA-ESBL vs. CA non-ESBL UTI). The yearly prevalence was calculated. Baseline characteristics and clinical course such as fever duration, laboratory and radiological findings were compared between the two groups. Risk factors associated with the CA-ESBL UTI were investigated.

Results: Among the enrolled infants (n=185), 31 (17%) had CA-ESBL UTI. The yearly prevalence of ESBL of CA-ESBL UTI increased during the study (0% in 2010, 22.2% in 2015). Infants with CA-ESBL UTI had a longer duration of fever after initiating antibiotics (2.0±1.1 vs. 1.5±0.6 days, p=0.020). Cortical defects on renal scan and early treatment failure were more frequent in CA-ESBL (64.5 vs. 42.2%, p=0.023; 22.6 vs. 4.5%, p=0.001). A logistic regression analysis revealed that urinary tract abnormalities and previous UTI were independent risk factors for CA-EBSL UTI (odds ratio, 2.7; p=0.025; 10.3; p=0.022).

Conclusion: The incidence of UTI caused by ESBL-producing bacteria has increased in Korean infants. Recognition of the clinical course and risk factors for ESLB-producing UTI may help to determine appropriate guidelines for its management.

Citing Articles

Analysis of antibiotic resistance and risk factors of extended-spectrum beta-lactamases-producing Escherichia coli in hospitalized children with community-acquired urinary tract infections.

Lin Y, Peng Q, Li W, Chen B Int Urol Nephrol. 2025; .

PMID: 39948286 DOI: 10.1007/s11255-025-04417-1.


Piperacillin-Tazobactam versus Cefotaxime as Empiric Treatment for Febrile Urinary Tract Infection in Hospitalized Children.

Han K, Oh M, Ahn J, Lee J, Kim Y, Yoon Y Infect Chemother. 2024; 56(2):266-275.

PMID: 38960740 PMC: 11224032. DOI: 10.3947/ic.2024.0020.


Urinary Tract Infections among Febrile Infants in Qatar: Extended-Spectrum-Beta-Lactamase (ESBL)-Producing Versus Non-ESBL Organisms.

Qusad M, Elhalabi I, Ali S, Siddiq K, Loay L, Aloteiby A Antibiotics (Basel). 2024; 13(6).

PMID: 38927213 PMC: 11200522. DOI: 10.3390/antibiotics13060547.


Predictive factors of urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli in children: a prospective Tunisian study.

Boussetta A, Kharbach N, Abdellatif A, Karray A, Jellouli M, Gargah T Tunis Med. 2023; 101(2):285-291.

PMID: 37682274 PMC: 11138556.


Analysis of Etiology of Community-Acquired and Nosocomial Urinary Tract Infections and Antibiotic Resistance of Isolated Strains: Results of a 3-Year Surveillance (2020-2022) at the Pediatric Teaching Hospital in Warsaw.

Wanke-Rytt M, Sobierajski T, Lachowicz D, Seliga-Gasior D, Podsiadly E Microorganisms. 2023; 11(6).

PMID: 37374940 PMC: 10301861. DOI: 10.3390/microorganisms11061438.